NewsRamp Science, Exploration and Discovery Podcast
Subscribed: 0Played: 1
Subscribe
Description
Explore the wonders of science with the 'NewsRamp Science Podcast.' Each episode offers the latest news and detailed summaries from NewsRamp.com, covering scientific breakthroughs, research advancements, and technological innovations. Stay informed on the discoveries that shape our understanding of the world.
151 Episodes
Reverse
NRx Pharmaceuticals Inc. is making waves on Wall Street with its groundbreaking therapies for suicidal bipolar depression. With promising drugs like NRX-100 and NRX-101, along with strategic moves like Fast Track Designation and removing toxic preservatives from ketamine products, NRx is poised for success in the biopharmaceutical industry. With a focus on offering life-saving therapies through HOPE Therapeutics, NRx is a company with significant potential in the treatment of a widespread and impactful condition.
Quantum BioPharma Ltd. plans a private placement for general working capital, while Ucore Rare Metals Inc. receives a $18.4 million award from the U.S. Department of Defense to fast-track its Louisiana Strategic Metals Complex, aiming to establish itself as a reliable North American source of heavy rare earth elements.
AAA Biotech has expanded its portfolio with more rProteins, offering researchers in life sciences access to high-quality recombinant proteins for various applications such as protein-protein interactions and drug discovery. Through rigorous quality control and customization options, AAA Biotech aims to support and advance biomedical research efforts. Visit their official website for more information on their research reagents.
Trusted clinical research partnerships drive medical advancements in treating pediatric gliomas and suicidal ideation, while mining companies like ESGold Corp. focus on revenue generation and mine site revitalization. Financial firms like Alliance Global Partners maintain optimistic outlooks for companies such as Soligenix Inc., while Quantum BioPharma Ltd. progresses with an oral formulation for multiple sclerosis treatment. Additionally, Oragenics Inc. makes strides towards developing a pharmacological treatment for concussion, and a study reveals the impact of stalking on women's cardiovascular health.
Chinese researchers have developed a groundbreaking treatment for lung cancer by transplanting mitochondria into tumors, enhancing chemotherapy effectiveness. Quantum BioPharma Ltd. collaborates with Massachusetts General Hospital on a PET tracer to detect MS-related changes and evaluates a neuroprotective drug for myelin sheath protection.
Stonegate Capital Partners provides an update on BlackSky Technology, Inc., highlighting revenue growth, new contracts, satellite launches, and a successful convertible note offering. The American Heart Association raises concerns about the health impact of ultraprocessed foods and emphasizes the importance of reducing consumption. Researchers introduce a new nanoelectromechanical system accelerometer using double-layer graphene membranes, offering high sensitivity and potential applications in various fields.
Join the Girl Scouts of Southeast Florida at STEMapalooza 2025 for a hands-on STEM learning experience. Soligenix Inc. is highlighted for its rare disease innovation with the HyBryte(TM) platform. ARTBIO, Inc. announces new board appointments for advancing alpha radioligand programs. LaFleur Minerals Inc. launches a drilling campaign at the Swanson Gold Project, while Aston Bay Holdings Ltd. reports copper intercepts at the Storm Copper Project. Additionally, a survey by D-Wave Quantum Inc. reveals business leaders' expectations for quantum optimization ROI, and McEwen Inc. reports strong financial performance and sustainability goals.
Energy Fuels Inc. reported record uranium grades at its Pinyon Plain mine and progress in rare earth operations, while GeoVax Labs, Inc. responded to HHS terminating mRNA vaccine contracts by advocating for MVA-based multi-antigen vaccines like GEO-CM04S1, highlighting deficiencies in mRNA vaccines and emphasizing the need for evidence-backed alternatives.
Lantern Pharma's subsidiary Starlight Therapeutics has received FDA clearance to begin a Phase Ib/2a clinical trial for glioblastoma multiforme treatment. Eloro Resources Ltd. reports positive assay results from drilling program in Bolivia. Additionally, a genetic discovery holds promise for enhancing cancer immunotherapy, particularly in ovarian clear cell carcinoma patients.
ABVC BioPharma secures a $2.5 million investment from international investors, signaling confidence in their therapeutic innovations. Meanwhile, a study from Denmark reveals that excessive screen time among youth is associated with increased heart health risks, emphasizing the importance of addressing screen habits to protect long-term health.
This podcast episode highlights recent advancements in various industries, including iRocket's partnership with SpaceBelt KSA for satellite launches, EnPlusOne Biosciences' enzymatic RNA synthesis technology, ProtoSpace Mfg's sponsorship of a planetary rover challenge, Soligenix Inc.'s efforts in developing treatments for rare diseases, the impact of chronic inflammation on depression treatments for diabetics, Quantum BioPharma Ltd.'s positive Phase 1 results for Lucid-MS in targeting multiple sclerosis, and Epic Medical Research's collaboration with hyperCORE International to expand clinical trial capabilities.
Intensity Therapeutics, Inc. secures $6.6 million for clinical trials, Trilogy Metals Inc. positions itself as a key player in the mining industry, a study explores EV battery reuse vs. recycling, and NRx Pharmaceuticals, Inc. petitions FDA for a ban on Benzethonium Chloride in ketamine products, focusing on developing safer therapeutics.
Neutra Life Sciences, a subsidiary of Neutra Corp, is expanding rapidly through joint venture partnerships with Podiatry Epic Foot & Ankle Centers, Radiation Oncology Aspire Hospital Cancer Centers, and Dermatology Radiant Dermatology & Aesthetics Clinic. This diversification into various specialties aims to meet the growing demand for high-quality clinical research solutions, accelerating the development of innovative treatments and reflecting a shift towards long-term growth in the life sciences sector.
Lahontan Gold Corp. and ESGold Corp. are leveraging past producers and innovative approaches to tap into the potential of gold mining, while researchers at the University of Kentucky have made strides in personalized cancer treatment through genetic biomarker identification for glioblastoma patients.
OncoX BioPharma, under the leadership of CEO Yen Wen Pin, is strengthening its collaboration with ABVC BioPharma by licensing four IND-stage drug assets to advance its immunotherapy-driven treatments in oncology. The partnership aims to create long-term value for patients and investors, with a focus on revenue-generating models and expansion into global markets to provide innovative therapies worldwide.
Oragenics Inc. partners with Southern Star Research for Phase IIa trial, Aston Bay Holdings Ltd. launches summer exploration program in Nunavut, and Soligenix achieves positive results in Behçet’s Disease study. Norvell Jefferson's BIO 2025 Pulse of the Industry Report highlights key forces driving innovation in the biotech sector.
Amerigo Scientific offers high-quality carotenoid standards with over 95% purity, ensuring accurate and reliable results for researchers in various fields. These standards meet strict quality control and stability requirements, providing confidence in data accuracy and compliance with global testing standards. Visit their website for more information.
NanoViricides, Inc. introduces NV-387 as a promising treatment for the rising measles cases in multiple countries, with potential for expedited approval. ESGold Corp. is gaining attention for its revenue-focused strategy of rehabilitating a legacy mine site in Quebec, aiming for profitable metal and mineral recovery.
Royalty Management Holding Corporation has expanded its sampling program at T.R. Mining, uncovering economically viable titanium, vanadium, and rare earth elements. With plans to extract and sell these valuable minerals, the company aims to hire local personnel in Jamaica, providing employment opportunities and maximizing the resource's value for shareholders and communities.
NanoCell Therapeutics, Inc. introduces a game-changing study on in vivo CAR-T cell generation, potentially transforming accessibility to $300,000 therapies. Ucore Rare Metals Inc. garners attention for its upcoming rare earths plant in Louisiana, poised to impact defense, EV, and electronics industries positively. Meanwhile, volatility in markets affects the oil and gas sector, with Nicola Mining Inc. making significant strides in gold-silver exploration in British Columbia.
Comments
Download from Google Play
Download from App Store
United States